当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > 多肽产品 > Rat CGRP-(8-37)
Rat CGRP-(8-37)
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:8年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:91228
参观次数:11409735
联系我们
MedChemExpress
电话:021-58955995
联系人:客服部 (请说明是在易推广看到的!谢谢)
手机:13611715263
邮编:201203
邮箱:sales@medchemexpress.cn
地址:上海上海
详细内容
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Rat CGRP-(8-37)
CAS No. : 129121-73-9
MCE 站:Rat CGRP-(8-37)
产品活性:Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) 是高度选择的 CGRP receptor 拮抗剂。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:CGRP Receptor
In Vitro: CGRP-(8-37) is a truncated version of calcitonin gene-related peptide (CGRP) that binds to the CGRP receptor with similar affinity but does not activate the receptor.
In Vivo: CGRP-(8-37) is effective in alleviating mechanical and thermal allodynia in a dose-dependent manner. The 50 nM dose is most efficacious for both forelimb and hindlimb responses. The period of efficacy is 10 min to onset for a duration of 20 min. Post-drug washout responses are not statistically significant compared to pre-drug responses. Intrathecal administration of 5 nmol or 10 nmol of CGRP-(8-37), but not 1 nmol, induces a significant increase in hindpaw withdrawal latency. Intrathecal administration of CGRP-(8-37) not only reverses the SP-induced decrease in latency to both withdrawal responses but also mediates a significant increase in response latency compared to basal levels.
相关产品:Bioactive Compound Library Plus | Olcegepant | Calcitonin (salmon) | Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA | β-CGRP, human TFA | Adrenomedullin (AM) (22-52), human | Calcitonin (human) | HCGRP-(8-37) | Ubrogepant | Adrenomedullin (11-50), rat | Adrenomedullin (16-31), human | Kendomycin | PHM-27 (human) | Adrenomedullin (1-50), rat | CGRP antagonist 1
热门标签:8-37